Introduction

36
From Drosophila to humans, the brain contains a vast array of morphologically and functionally distinct 37 neurons and glia that arise from a much smaller pool of neural progenitors. How neural stem cells generate 38 neural diversity is a fundamental question that is relevant to many areas of biology. For example, 39 understanding normal neurodevelopmental programs may help design reprogramming protocols to replace 40 specific neurons in clinical trials; may help elucidate principles of connectivity based on shared developmental 41 features; and may help reveal how proliferative neural progenitors avoid tumor formation without 144 match normal 25 o C staging, see methods) and for controls we either assayed the same ecd ts homozygous larvae 145 at the permissive temperature of 18 o C or age-matched wild type larvae (controls). As expected, control larvae 146 at 72h or 96h had type II neuroblasts that expressed the late factors Syncrip, Broad and E93, but not the early 147 factors Chinmo and Imp (Figure 2A -E; quantified in K). In contrast, ecd ts homozygous larvae at 29 o C had type 148 II neuroblasts that persistently expressed the early factors Chinmo/Imp and lacked the late factors 149 Syncrip/Broad/E93 (Figure 2F-J; quantified in K). We conclude that systemic reduction of ecdysone levels 150 blocks the Chinmo/Imp to Broad/Syncrip/E93 gene expression transition in type II neuroblasts.
152
Loss of ecdysone signaling could block cell cycle progression of type II neuroblasts, which could prevent the 153 early-to-late gene expression transition. To test this hypothesis, we isolated larval brains and cultured them in 154 vitro from 48-72h (across the early-to-late transition) with or without the bioactive form of ecdysone (20-155 hydroxy-ecdysone; 20HE). We used live imaging to measure cell cycle times, as well as assayed for expression 156 of representative early or late factors. Larval brains cultured with added ecdysone are similar to wild type in 6 3E-F, quantified in G; Videos 1,2), and similar to published type II neuroblast cell cycle times (Homem et al., 162 2013). Taking these results together with our in vivo ecdysone experiments, we conclude that the steroid 163 hormone ecdysone induces the early-to-late Chinmo/Imp to Broad/Syncrip/E93 gene expression transition in 164 type II neuroblasts.
166
The Ecdysone receptor EcR-B1 is expressed concurrent with, and required for, the early-to-late gene 167 expression transition in larval brain neuroblasts 168 169
The ability of ecdysone signaling to trigger a major gene expression transition at ~60h could be due to a peak 170 of ecdysone signaling at that time, or the lack of a signaling pathway component prior to that time. Ecdysone 171 is present at all larval stages (Kozlova and Thummel, 2000), suggesting the latter mechanism. Ecdysone 172 signaling is quite direct, requiring the Ecdysone receptor (EcR-A, -B1, or -B2 isoforms) and the ubiquitous co-173 receptor Ultraspiracle (Lee et al., 2000) . We found that EcR-B1 was strongly detected in the nuclei of type II 174 neuroblasts from 56h to at least 120h; prior to 56h neuroblasts did not express any EcR isoform ( Figure 4B ; a different EcR receptor isoform) we assayed ecd ts mutants at non-permissive temperature and assayed for EcR-177 B1 expression; we also assayed for EcR-B1 expression in brain explants cultured with or without exogenous 178 ecdysone. In both experiments, we found that expression of EcR-B1 was not dependent on ecdysone signaling 179 ( Figure 4C -F). Note that normal EcR expression during the culture window provides evidence that there is no 180 general developmental delay in brains lacking ecdysone signaling, despite failure to undergo the Chinmo/Imp 181 to Broad/Syncrip/E93 transition. We conclude that an ecdysone-independent pathway activates EcR-B1 182 expression at 56h, the time of the Chinmo/Imp to Broad/Syncrip/E93 gene expression transition 183 (summarized in Figure 4M ).
184
To determine if EcR was required for the Chinmo/Imp to Broad/Syncrip/E93 gene expression 185 transition, we used wor-gal4 ase-gal80 to drive expression of a dominant-negative Ecdysone receptor (EcR-186 B1 W650A ; subsequently EcR DN ) specifically in type II neuroblasts, and assayed representative early and late 187 factors. We found that neuroblasts expressing EcR DN showed completely penetrant persistent expression of 188 the early factors Chinmo and Imp, and reduced or no expression of the late factors Syncrip (reduced) and E93 189 (absent) ( Figure 4G -I,K; quantified 4L). Surprisingly, the late factor Broad was normally expressed ( Figure 4H ; 190 quantified in 4L; see Discussion), again suggesting no general developmental delay. We conclude that ecdysone 191 signaling acts via EcR-B1 within type II neuroblasts to promote the Chinmo/Imp/Lin-28 to 192 Broad/Syncrip/E93 gene expression transition.
194
The Seven-up nuclear hormone receptor activates EcR in larval brain neuroblasts 195 7 Previous work has shown that svp mutant clones fail to down-regulate Chinmo/Imp in late-born neurons 197 (Narbonne-Reveau et al., 2016). Svp could promote EcR expression, or act in parallel to EcR to down-regulate 198 Chinmo/Imp. To distinguish between these alternatives, we examined svp mutant clones for EcR expression.
199
We induced svp mutant clones at 0-4h and assayed them at 96h. As expected, we observed a highly penetrant 200 failure to down-regulate expression of the early factors Chinmo/Imp ( Figure 5A 202 quantified in G). We conclude that Svp is required to induce EcR expression, and that EcR expression renders 203 neuroblasts competent to respond to ecdysone signaling.
204
Svp could directly activate EcR expression, or alternatively Svp could terminate Cas expression and 205 Cas could repress EcR (double repression motif). We assayed svp mutant clones for Cas expression, and did 206 not observe prolonged Cas expression ( Figure 5-figure supplement 1 ). In addition, cas mutant clones showed 207 no change in early or late temporal factor expression (data not shown; T. Lee, personal communication). We 208 conclude that Svp uses a Cas-independent mechanism to activate EcR expression in type II neuroblasts.
210
Syncrip represses Imp expression to allow down-regulation of Chinmo in larval neuroblasts
212
We wanted to characterize the genetic interactions occurring downstream of the Ecdysone receptor, to better 213 understand the mechanism of the early-to-late gene expression transition. Does each affected gene respond 214 independently to EcR, or is there a cascade of interactions occurring downstream of a single primary EcR 215 target gene?
216
First, we tested whether the Imp and Syncrip proteins are downstream of EcR-B1. We observed 217 normal EcR-B1 timing and levels in both Imp and Syncrip mutants ( Figure 6A -C), confirming that they act in 218 parallel or downstream of EcR-B1. Second, we tested whether Imp and Syncrip cross-repress each other, as 219 has been shown for mushroom body neuroblasts (Liu et al., 2015) . We found that Syncrip mutants had 220 prolonged Imp expression in type II neuroblasts, but that Imp mutants did not show precocious Syncrip 221 expression in the six DM1-DM6 type II neuroblasts ( Figure 6D -E); there was variable precocious expression 222 in one of the DL1/2 type II neuroblasts at 48h (data not shown). We conclude that the regulatory interactions 223 between Imp and Syncrip are neuroblast-specific. Third, we assayed Imp and Syncrip mutants for changes in 224 early and late factor expression. Whereas Imp mutants had no change in expression of the early factor Chinmo 225 or late factors Broad and E93 ( Figure 6F -H), Syncrip mutants showed prolonged expression of early factor 226 Chinmo but normal expression of the late factors Broad and E93 ( Figure 6I -K), leading to a novel Chinmo+ 227 Broad+ co-expression molecular profile ( Figure 6N ). Lastly, we tested for cross-repression between the early 228 factor Chinmo and the late factor Broad, as these proteins are typically mutually exclusive in both neuroblasts Here we show that the steroid hormone ecdysone is required to trigger a major gene expression transition at 270 mid-larval stages: central brain neuroblasts transition from Chinmo/Imp to Broad/Syncrip/E93. Furthermore,
271
we show that Svp activates expression of EcR-B1 in larval neuroblasts, which gives them competence to 272 respond to ecdysone signaling, thereby triggering this gene expression transition. Although a global reduction 273 of ecdysone levels is likely to have pleiotropic effects on larval development, we have performed multiple 274 experiments to show that the absence or delay in late temporal factor expression following reduced ecdysone 275 signaling is not due to general developmental delay. First, the EcR gene itself is expressed at the normal time 276 (~56h) in the whole organism ecdysoneless 1 mutant, arguing strongly against a general developmental delay.
277
Second, a type II neuroblast seven-up mutant clone shows a complete failure to express EcR and other late 278 factors, in the background of an entirely wild type larvae; this is perhaps the strongest evidence that the 279 phenotypes we describe are not due to a general developmental delay. Third, lineage-specific expression of 280 EcR dominant negative leads to loss of Syncrip and E93 expression without affecting Broad expression; the 281 normal Broad expression argues against a general developmental delay. Fourth, we used live imaging to directly 282 measure cell cycle times and found that lack of ecdysone did not slow neuroblast cell cycle times. Taken 283 together, these data support our conclusion that ecdysone signaling acts directly on larval neuroblasts to 284 promote an early-to-late gene expression transition. 
296
Does ecdysone signaling provide an extrinsic cue that synchronizes larval neuroblast gene expression?
297
We do not see good coordination of late gene expression, arguing against synchronization. For example,
298
Syncrip can be detected in many neuroblasts by 60h, whereas Broad appears slightly later at ~72h, and E93 is 299 only detected much later at ~96h, by which time Broad is low. This staggered expression of ecdysone target 300 genes is reminiscent of early and late ecdysone-inducible genes in other tissues (Baehrecke, 1996) . In addition, 10 for any particular temporal factor there are always some neuroblasts expressing it prior to others, but not in an 302 obvious pattern. It seems the exact time of expression can vary between neuroblasts. Whether the pattern of 303 response due to different neuroblast identities, or a stochastic process, remains to be determined.
304
We have previously shown that the Hunchback-Krüppel-Pdm-Castor temporal gene transitions within 
315
B1 levels in young neuroblasts (data not shown). Perhaps there is another required factor that is also 316 temporally expressed at 56h. We also note that reduced ecdysone signaling in ecd ts mutants or following EcR DN 317 expression does not permanently block the Chinmo/Imp to Broad/Syncrip/E93 transition; it occurs with 318 variable expressivity at 120-160h animals (pupariation is significantly delayed in these ecd ts mutants), either due 319 to a failure to completely eliminate ecdysone signaling or the presence of an ecdysone-independent 320 mechanism.
321
We find a small but reproducible difference in the effect of reducing ecdysone levels using the 322 biosynthetic pathway mutant ecd ts versus expressing a dominant negative EcR in type II neuroblasts. The 323 former genotype shows a highly penetrant failure to activate Broad in old neuroblasts, whereas the latter 324 genotype has normal expression of Broad (despite failure to down-regulate Chinmo/Imp or activate E93).
325
This may be due to failure of the dominant negative protein to properly repress the Broad gene. Differences 
349
The position of the Svp+ neuroblasts varied among the type II neuroblast population from brain-to-350 brain, suggesting that Svp may be expressed in all type II neuroblasts but in a transient, asynchronous manner.
351
This conclusion is supported by two findings: the svp-lacZ transgene, which encodes a long-lived β-352 galactosidase protein, can be detected in nearly all type II neuroblasts; and our finding that Svp is required for producing Kenyon cells; one high diversity, suitable for generating distinct olfactory projection neurons). Here 375 we find that larval type II neuroblasts undergo at least seven molecularly distinct temporal windows (Figure 9 ).
376
If we assume that the graded expression of Imp (high early) and Syncrip (high late) can specify fates in a 377 concentration-dependent manner, many more temporal windows could exist. 
512
(F-K) Early factors. Chinmo, Imp, and Lin-28:GFP (Lin-28) are detected in neuroblasts at 48h but not at 72h.
513
(L-Q) Late factors. Syncrip, Broad, and E93 are not detected in neuroblasts at 48h but are present at 72h or 
528
(K) Quantification. n >10 for each bar. Asterisk, p < 0.003.
529
In all panels, times are adjusted to the equivalent larval stage at 25 o C, type II neuroblasts are identified as 530 Dpn+ Ase-or large cells expressing wor-gal4 ase-gal80 UAS-mcd8:GFP (green in insets). Scale bar, 10μm. 
577
(D) Imp mutants (Imp G0072 / Imp G0072 ) do not precociously upregulate Syncrip in type II neuroblasts at 48h.
578
(E) Syncrip mutants (Syncrip f03775 / deficiency) show prolonged expression of Imp in type II neuroblasts at 72h.
18
(F-H) Imp mutants (Imp G0072 / Imp G0072 ) show normal temporal expression of Chinmo, Broad, or E93 in type II 580 neuroblasts.
581
(I-K) Syncrip mutants (Syncrip f03775 / deficiency) show prolonged expression of Chinmo but normal expression of 582 the late factors Broad and E93 in type II neuroblasts.
583
(L) broad mutants (broad npr3 / broad npr3 ) have normal Chinmo expression: absent from 72h type II neuroblasts.
584
(M) chinmo mutants (chinmo 1 mutant clones) have normal Broad expression: absent from 48h type II 585 neuroblasts.
586
(N) Syncrip mutants (Syncrip f03775 / deficiency) have type II neuroblasts that abnormally co-express Chinmo and 587 Broad at 72h.
588
(O) Quantification. Percent of type II neuroblasts expressing the indicated factors at the indicated timepoints.
589
Insets identify the pictured type II neuroblast (green) based on its expression of Dpn (green) not Ase (red) or 590 by expression of wor-gal4 ase-gal80 UAS-mcd8:GFP (green). n > 5 for all panels. Scale bar, 10 μm. 
618
Two type II neuroblasts are shown expressing wor-gal4 ase-gal80 UAS-myr:GFP (see methods). Still panels from 619 video shown in Figure 3E , and cell cycle times quantified in Figure 3G . 620 621 Video 2. Explanted larval brain cultured in vitro from 48-72h without 20-hydroxy-ecdysone.
622
Two type II neuroblasts are shown expressing wor-gal4 ase-gal80 UAS-myr:GFP (see methods). Still panels from 623 video shown in Figure 3F , and cell cycle times quantified in Figure 3G . 
636
(B) Broad-Z3 (magenta) is not detected in type II neuroblasts (dashed circle) at 96h.
637
In all panels, type II neuroblast lineages are marked by wor-gal4 ase-gal80 UAS-cd8:GFP expression (green). 
641
(B) EcR-A (magenta) is not detected in type II neuroblasts (dashed circle) at 96h; n>10.
642
(C) EcR-common (magenta) is not detected in type II neuroblasts (dashed circle) at 48h; n>10.
643
(D) EcR-common (magenta) is detected in type II neuroblasts (dashed circle) at 72h; n>10.
644
EcR-common detects all EcR isoforms. In all panels, type II neuroblast lineages are marked by wor-gal4 ase-645 gal80 UAS-cd8:GFP expression (green). Scale bar, 10 μm. 
660
In all panels, type II neuroblast lineages are marked by wor-gal4 ase-gal80 UAS-cd8:GFP expression (green). Scale 661 bar, 10 μm. 
